# Cytori Therapeutics, Inc.

- Location (FDA's records): San Diego, CA
- FDA decisions: 6 (2006–2014): 6 510(k) clearances
- Product codes: MUU (4), CAC (1), QPB (1)
- Predicates its devices cite: 15 (4 its own); citations of its devices by later devices: 9 (4 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Dideco S.P.A.: 2 (https://510kreport.com/company/dideco)
- Shippert Medical Technologies Corp.: 2 (https://510kreport.com/company/shippert-medical-technologies)
- Macropore Biosurgery, Inc.: 2 (https://510kreport.com/company/macropore-biosurgery)
- Medtronic Blood Management: 1 (https://510kreport.com/company/medtronic-blood-management)
- Exel Intl.: 1 (https://510kreport.com/company/exel-intl)
- Flow Laboratories, Inc.: 1 (https://510kreport.com/company/flow-laboratories)
- Oxoid U.S.A., Inc.: 1 (https://510kreport.com/company/oxoid-usa)
- Lipose Corp.: 1 (https://510kreport.com/company/lipose)

## Firms that cite its devices most
- Medi-Khan USA, Inc.: 1 (https://510kreport.com/company/medi-khan-usa)
- Human Med AG: 1 (https://510kreport.com/company/human-med)
- Biomet, Inc.: 1 (https://510kreport.com/company/biomet)
- Shippert Medical Technologies Corp.: 1 (https://510kreport.com/company/shippert-medical-technologies)
- Lipose Corp.: 1 (https://510kreport.com/company/lipose)

## Its most-cited devices
- K072587: Cytori Aft System (2007), cited by 6
- K092923: Cytori Puregraft 250/Pure System (2010), cited by 2
- K113255: Puregraft 850/Pure System (2012), cited by 1

## Recent decisions
- K132815: Puregraft 50 System (Jan 24, 2014)
- K113255: Puregraft 850/Pure System (Mar 7, 2012)
- K092923: Cytori Puregraft 250/Pure System (Jan 6, 2010)
- K072587: Cytori Aft System (Dec 10, 2007)
- K063235: Cytori Lipoplasty System with Celase Reagent (Jan 24, 2007)
- K060482: Cytori Celution Cell Concentration Device (Sep 28, 2006)

Source page: https://510kreport.com/company/cytori-therapeutics